Less Ads, More Data, More Tools Register for FREE

Pin to quick picksZotefoams Regulatory News (ZTF)

Share Price Information for Zotefoams (ZTF)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 562.00
Bid: 564.00
Ask: 576.00
Change: -2.00 (-0.35%)
Spread: 12.00 (2.128%)
Open: 564.00
High: 574.00
Low: 562.00
Prev. Close: 564.00
ZTF Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

MuCell Extrusion LLC Obtains an Exclusive License

14 Aug 2012 07:00

RNS Number : 9308J
Zotefoams PLC
14 August 2012
 



14 August 2012

 

Zotefoams plc

("Zotefoams" or "the Company")

 

 

MuCell Extrusion LLC Obtains an Exclusive License for Styron's

Extruded Styrenic Foam Sheet Patent Portfolio, including Polystyrene, ABS and SAN

 

MuCell Extrusion LLC and Styron (Berwyn, Pennsylvania) have concluded an agreement for MuCell Extrusion LLC to acquire access to Styron's patent portfolio for extrusion of Styrenic resins. This agreement gives MuCell Extrusion and its customers exclusive rights to the Styron patents related to Sheet technology for a wide variety of applications.

 

This agreement creates a significant strategic alliance between two companies with leading experience in the successful development and application of physical blowing agents to produce superior foamed products.

 

The combination of Styron's CO2RE™ technology and MuCell's expertise around technology and hardware is expected to help customers improve their competitive advantage in a shorter timeframe. Sheet for thermoforming, FFS, roll stock, paneling and high volume packaging will all see significant cost reductions by applying this technology.

 

 "CO2RE™ is a patented plastic foaming technology that produces polystyrene sheets with a foamed core layer using physical blowing agents," said John Case, Styrenics Global Marketing Manager, Styron. "The technology provides a good opportunity for the packaging market, where for example dairy and food service industries can improve their sustainability by reducing the density and weight of their product packaging. It also provides benefits in reduced energy and reduced raw material usage, as well as lower packaging waste disposable tax in the EU."

 

"MuCell provides expertise in Process and Equipment development, and Styron offers formulation expertise in resins. We believe this combination will bring significant benefits to our customers," said Mark Lindenfelzer, President of MuCell. "The combination of our own patents and intellectual property, and Styron's patents now gives our customers the opportunity to apply the most advanced foaming technology in their products," he said.

 

About MuCell Technology

MuCell technology is based on the direct injection of atmospheric gas (N2 or CO2) in its supercritical state. MuCell has applied this technology to most plastic materials and processes. Rigid sheet, low-density flexible sheet, Blown film, Cast film, pipe/tubing/profile, and blow molding manufacturing processes are all current applications using MuCell technology. MuCell's innovative and accessible technology brings significant material weight-savings and cost reduction opportunities, without compromising physical product performance.

 

Earlier this year, Dow Chemical and MuCell reached an agreement for MuCell to acquire exclusive rights to Dow's patent portfolio for flat sheet resin technology, and more recently Dow's patents for Foam Film technology.

 

The corporate headquarters of MuCell Extrusion LLC are located at 212 West Cummings Park, Woburn, MA 01810. MuCell Extrusion is a wholly owned subsidiary of Zotefoams plc, UK (ZTF on LSE). For more information, please visit www.mucellextrusion.com.

 

About Styron

Styron is a leading global materials company and manufacturer of plastics, latex and rubber, dedicated to collaborating with customers to deliver innovative and sustainable solutions. Styron's technology is used by customers in industries such as home appliances, automotive, building & construction, carpet, consumer electronics, consumer goods, electrical & lighting, medical, packaging, paper & paperboard, rubber goods and tires. Styron had approximately $6 billion in revenue in 2011, with 20 manufacturing sites around the world, and 2100 employees. More information can be found at www.styron.com.

 

###

 

For Styron editorial information please contact:

Donna St. Germain, Styron

Tel. +1 610 240 3307

stgermain@styron.com

 

 

For information on MuCell Extrusion LLC and Zotefoams plc contact:

 

Zotefoams plc

Clifford Hurst or David Stirling

+44 20 8664 1600

 

FTI Consulting

John Dineen / Victoria Foster Mitchell

+44 20 7831 3113

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCBKNDDFBKDPFD
Date   Source Headline
19th Jul 20219:26 amRNSNotice of Results
13th Jul 20211:59 pmRNSDirector/PDMR Shareholding
14th Jun 20213:06 pmRNSDirector/PDMR Shareholding
14th Jun 202111:35 amRNSDirector/PDMR Shareholding
10th Jun 20214:41 pmRNSDirector/PDMR Shareholding
9th Jun 20213:48 pmRNSDirector/PDMR Shareholding
2nd Jun 20213:49 pmRNSHolding(s) in Company
26th May 202112:08 pmRNSResult of AGM
26th May 20217:00 amRNSTrading Update
12th May 20213:44 pmRNSDirector/PDMR Shareholding
28th Apr 20212:05 pmRNSDirector/PDMR Shareholding
26th Apr 20213:16 pmRNS2020 Annual Report, Notice of the 2021 AGM
13th Apr 20212:06 pmRNSDirector/PDMR Shareholding
12th Apr 20214:09 pmRNSDirector/PDMR Shareholding
25th Mar 20211:26 pmRNSDirector/PDMR Shareholding
23rd Mar 20213:19 pmRNSCorrection: Preliminary Results
23rd Mar 20217:00 amRNSPreliminary Results
12th Mar 20212:53 pmRNSDirector/PDMR Shareholding
10th Mar 20211:12 pmRNSHolding(s) in Company
9th Mar 20213:13 pmRNSHolding(s) in Company
9th Mar 20213:05 pmRNSHolding(s) in Company
9th Mar 20211:55 pmRNSHolding(s) in Company
8th Mar 20213:04 pmRNSResult of secondary placing in Zotefoams plc
8th Mar 202112:00 pmRNSProposed secondary placing in Zotefoams plc
8th Mar 20217:00 amRNSNotice of results and investors presentation
5th Mar 20214:36 pmRNSPrice Monitoring Extension
23rd Feb 20217:00 amRNSProduction starts at new £23m plant in Poland
15th Feb 20217:00 amRNSPolish factory virtual tour and investor Q&A
12th Feb 20214:20 pmRNSDirector/PDMR Shareholding - Replacement
12th Feb 20213:54 pmRNSDirector/PDMR Shareholding
12th Feb 20213:38 pmRNSDirector/PDMR Shareholding
8th Feb 20214:41 pmRNSSecond Price Monitoring Extn
8th Feb 20214:35 pmRNSPrice Monitoring Extension
21st Jan 20217:00 amRNSOperational and Trading Update
12th Jan 20213:50 pmRNSDirector/PDMR Shareholding
14th Dec 20204:19 pmRNSDirector/PDMR Shareholding
12th Nov 20203:40 pmRNSDirector/PDMR Shareholding
5th Nov 20207:00 amRNSOperational and Trading Update
22nd Oct 202010:36 amRNSDirector/PDMR Shareholding
14th Oct 20207:00 amRNSDirector/PDMR Shareholding
9th Oct 20207:00 amRNSDirector/PDMR Shareholding
7th Oct 20207:00 amRNSExternal Auditor Appointment
1st Oct 20204:13 pmRNSDirector/PDMR Shareholding
16th Sep 20204:29 pmRNSDirector/PDMR Shareholding
11th Sep 20204:41 pmRNSSecond Price Monitoring Extn
11th Sep 20204:35 pmRNSPrice Monitoring Extension
9th Sep 20205:51 pmRNSHolding(s) in Company
1st Sep 20204:40 pmRNSSecond Price Monitoring Extn
1st Sep 20204:35 pmRNSPrice Monitoring Extension
18th Aug 202010:54 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.